Transcription factor ASCL1 targets SLC6A13 to inhibit the progression of hepatocellular carcinoma via the glycine-inflammasome signaling. (2024). Biomolecules and Biomedicine, 24(6), 1606–1619. https://doi.org/10.17305/bb.2024.10328